Searched for
PARTIAL ONSET SEIZURES
Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clea...- Indoco Remedies gets USFDA nod to sell generic epilepsy medicineIndoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to trea...
- Biocon arm gets USFDA nod for generic Everolimus tabletsBiocon's arm, Biocon Pharma Ltd, has secured USFDA approval for its generic Everolimus tablets. This medication aids in treating tuberous s...
- Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in USThe potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, respiratory depression...
- Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medicationZydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat pa...
- Granules India receives USFDA approval for generic gabapentin tabletsThese tablets are bioequivalent to the reference listed drug product, Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty LLC.
- Nipah Virus: Symptoms, prevention, treatment of the infection, everything you need to knowSo far, the infection has claimed 16 lives in Kerala.
- Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...
- Sun Pharma to launch complete range of generic anti-epilepsy drugThe drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solut...
- Lupin gets USFDA nod to market its postherpetic neuralgia drugThe company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.
- Aurobindo gets USFDA nod for epilepsy, arthritis drugsLevetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...
- FDA approves first 3D-printed drugIn a world first, the US has approved a 3D-printed drug to treat certain types of seizures in epilepsy patients.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- Sun Pharma Advanced Research Company shares surge 15 per cent; m-cap up by Rs 1,685 croreStocks of Sun Pharma Advanced Research Company Ltd surged 15 per cent today after the company received approval from the US health regulato...
- SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 croreELEPSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients of 12 years of age and older with epi...
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Lupin gets final US FDA nod for generic anti-epileptic drugLupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.
- US FDA approves Sun's new drug to market Topamax, topiramateSun Pharma today said the US Food and Drug Administration (FDA) has granted an approval for its abbreviated new drug application to market ...
- Sun Pharma announces USFDA approval for Topamax tabletsSun Pharma said US health regulator Food and Drug Administration has approved its Abbreviated New Drug Application (ANDA) to market generic...
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
Load More
